There is considerable public, regulatory, and scientific concern regarding human exposure to endocrine-disrupting chemicals, which include compounds that directly modulate steroid hormone receptor pathways (estrogens, antiestrogens, androgens, antiandrogens) and aryl hydrocarbon receptor (AhR) agonists, including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Based on quantitative structure-activity relationships for both AhR and estrogen receptor (ER) agonists, the relative potency (RP) of individual compounds relative to a standard (e.g., TCDD and 17f-estradiol) have been determined for several receptor-mediated responses. Therefore, the TCDD or estrogenic equivalent (TEQ or EQ, respectively) of a mixture is defined as TEQ= £[ TI x RPi or EQ= E EiE] x RP,, where T, and Ej are concentrations of individual AhR or ER agonists in any mixture. This approach for risk assessment of endocrine-disrupting mixtures assumes that for each endocrine response pathway, the effects of individual compounds are essentially additive. This paper will critically examine the utility of the TEQ/EQ approach for risk assessment, the validity of the assumptions used for this approach, and the problems associated with comparing low dose exposures to xeno and natural (dietary) endocrine disruptors. Environ Health Perspect 1 06(Suppl 4):1051-1058 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-4/ 1051-1058safe/abstract.html
Introduction
The potential adverse impacts of chemicals are dependent on a number of factors, including levels and duration of exposure, chemical potency, timing of exposure, mechanism of action, and interactions between chemicals in a mixture. Hazard and risk assessment of chemicals carried out by regulatory agencies have focused primarily on the toxicities of individual compounds, whereas wildlife and humans are exposed to complex mixtures of man-made compounds that act through multiple pathways. Moreover, the human diet contains many natural products and cooking-derived compounds that exhibit many of the same toxic, mutagenic, and carcinogenic properties of industrial-derived contaminants (1) (2) (3) . In most cases, humans are exposed to significantly higher levels of natural products than the man-made chemical toxicants that act through the same pathway. For example, early development of the Ames test for detecting bacterial mutagens generated considerable scientific, regulatory, and public concern over human exposure to the many different industrial chemicals that exhibited mutagenic activity in one or more of the highly sensitive bacterial tester strains (4, 5) . Subsequent studies demonstrated that some of the most mutagenic compounds in the human diet are not industrial-derived contaminants, but natural compounds that include a complex series of heterocyclic aromatic amines derived from cooking proteinaceous foods (e.g., fish, beef, poultry) (6) (7) (8) . Thus, the public health concern regarding human exposure to mutagens must take into account intake and potency of both natural and man-made chemicals that act through various pathways.
Hazard and risk assessment of human exposures to chemicals must also take into account scenarios where chemical interactions may significantly influence toxic outcomes. For example, despite relatively high levels of human exposure to natural carcinogens in the diet, there are several other classes of natural products (e.g., flavones, antioxidants) that inhibit P450-mediated metabolic activation or induce detoxifying enzymes, and these compounds may provide protection against natural or manmade toxins (9) (10) (11) . In contrast, workplace or environmental exposures to nontoxic levels of organochlorine solvents such as chloroform may lead to hepatotoxic effects if there is concurrent exposure to ketones because of their nonadditive (synergistic) interactions (12, 13 (29, 30) . HAHs are also routinely detected as residues in diverse food products, and the diet is the major source of human exposure to HAHs (30, 32) . evidence that TEFs do not always predict relative congener potency in different rat strains (61) . Several studies have also demonstrated that the coplanar PCBs 
Toxic Equivalency Factor Approach for Endocrine Disruptors
It has been hypothesized that industrialderived estrogenic compounds (xenoestrogens) and possibly other naturally occurring estrogens may be responsible for a global decrease in male reproductive capacity (e.g., sperm counts) and increased incidence of breast cancer in women (85, 86) . The validity of these hypotheses has been questioned (1, 87) , and resolution of the role of hormonally active compounds in human disease requires further study.
Like AhR agonists, hormonelike compounds that act through specific cellular receptors should be good candidates for using a TEF approach. Verdeal The in vivo activity of natural and man-made endocrine active agents are significantly influenced by their uptake, distribution, and metabolism. For example, many of the organochlorine xenoestrogens exhibit low estrogenic potency based on results of in vitro bioassays; however, these compounds persist in the environment and bioaccumulate. In contrast, many naturally occurring estrogenic flavonoids in foods are rapidly metabolized. For example, studies in this laboratory (94) showed that naringenin, a flavonoid in grapefruit juice, exhibited estrogenic activity in in vitro bioassays, whereas at doses as high as 30 to 40 mg/animal naringenin, did not induce estrogensensitive responses in the rat uterus. In contrast, in female rats cotreated with E2 plus naringenin, there was significant inhibition of E2-induced uterine wet weight, progesterone receptor levels, peroxidase activity, and DNA synthesis. Bisphenol A and p-octylphenol are two estrogenic phenolic compounds that exhibit similar estrogenic potency in a number of in vitro assays (90) . Vom Saal and co-workers (95) recently reported that prenatal to early postnatal exposure of mice to bisphenol A resulted in increased prostate weight in adult male offspring, whereas p-octylphenol was inactive in this model. The increased toxicity of bisphenol A compared to poctylphenol was associated with preferential binding of the latter compound to serum proteins and decreased uptake in target cells. In contrast, research in this laboratory in the immature female rat uterus indicated that nonylphenol was significantly more potent than bisphenol A, which exhibited weak ER agonist and partial antiestrogenic activity. Thus, the potencies of both 
Interacdons between Endocrine Response Pathways
The TEF/EQ approach is most applicable for hazard and risk assessment of a specific class of endocrine active compounds that act through a common receptor. However, as noted previously, there are a number of factors that complicate this approach and the problems are magnified with xenoendocrine active agents that act through steroid hormone receptor or thyroid hormone receptor-mediated pathways. For example, assessment of xenoestrogen exposure and potency (EQs) is complicated by tissue-specific agonist/antagonist activities, lack of data on intake and serum levels, and their relative contribution to total estrogen equivalents compared to much higher intakes of natural estrogenic chemicals in the diet (1). In addition, many compounds may interact with more than one hormone receptor and modulate multiple endocrine response pathways. For example, 2',3',4',5'-tetrachloro-2-biphenylol binds to the ER and exhibits ER-agonist activities (100, 101) . The same compound also binds to the androgen receptor in a yeast-based assay but inhibits dihydrotestosterone-induced reporter gene activity in human Hep G2 liver cancer cells transiently transfected with the human androgen receptor and an androgenresponsive construct (102) . Although 2',3',4',5'-tetrachloro-4-biphenylol did not bind the progesterone receptor, in a progesterone-responsive yeast assay this hydroxy-PCB inhibited progesterone receptor-mediated transactivation (103) . These data illustrate how one endocrineactive compound can modulate multiple endocrine response pathways.
Another major problem for hazard assessment of xenoestrogens is associated with tissue-specific cross talk between different receptor-mediated pathways, which can lead to significant modulation of estrogen-induced responses. It has been pointed out that in human breast cancer cells, cross talk between the ER-and AhR-signaling pathway results in inhibition of estrogeninduced responses (1) . Although this interaction is likely to be cell specific, it is possible that the estrogenic activity associated with xenoestrogens in the mammary gland will be inhibited by both xeno AhR and natural AhR agonists in the diet. Research in this laboratory has also focused on cross talk between the ER and other receptors that bind natural dietary constituents. Vitamin A, retinoids, phytol, and phytanic acid are vitamins or plant degradation products and are also important dietary constituents that act through the retinoic acid and retinoic acid X receptors, and there is cross talk between these receptors and the ER. For example, all transretinoic acid, 9-cis-retinoic acid, and phytol inhibit estrogen-induced responses in breast cancer cells, and any effects of xenoestrogens in these cells would be opposed by retinoic acid and retinoic acid X receptor ligands. The importance of this type of counteractive cross talk in other tissues and organs has not been determined. These are only some examples of cross talk between endocrine-signaling pathways that must be considered in an overall risk assessment of dietary exposure to xenoestrogens and other xenoendocrine active compounds, as well as natural compounds in food that act through the same signaling pathways.
Summary
Humans and wildlife are exposed in the diet to complex mixtures of natural and man-made chemicals. Hazard and risk assessment of these mixtures is a difficult process and the TEF approach has been utilized for several different classes of chemicals, including HAHs (AhR agonists), PAHs (carcinogens), and xenoestrogens (ER agonists). This review has pointed out both the utility and problems associated with the TEF approach for all three classes of chemicals. For example, although TEFs may be useful for regulating HAH emissions and cleanup levels, application of this concept for determining dietary TEQ intakes is complicated by the unknown contributions of naturally occurring AhR agonists, which exhibit both AhR agonist and antagonist activities (2) . Moreover, the issue of cross talk between multiple endocrine pathways would further compromise the validity of the TEF approach when applied to dietary intakes of different classes of man-made and natural chemicals. Based on these uncertainties, the TEF approach should be used for limited applications and only after validation in animal models.
